Shorter hospitalization trends among children with sickle cell disease

Jean L Raphael1, Brigitta U Mueller, Marc A Kowalkowski

  • 1Department of Pediatrics, Baylor College of Medicine, Texas Children's Cancer Center, Houston, Texas 77030, USA. Raphael@bcm.edu

Pediatric Blood & Cancer
|January 7, 2012
PubMed

Insights

Hospital stays for vaso-occlusive crises (VOC) in children with sickle cell disease (SCD) decreased between 1997 and 2009. Length of stay (LOS) reduced, particularly for adolescents, indicating improved care for pediatric SCD patients.

Area of Science:

  • Pediatric Hematology
  • Public Health
  • Health Services Research

Background:

  • Vaso-occlusive crises (VOC) are a primary cause of hospitalization for pediatric patients with sickle cell disease (SCD).
  • Understanding trends in hospital length of stay (LOS) for VOC is crucial for resource allocation and care improvement.

Purpose of the Study:

  • To analyze changes in pediatric length of stay (LOS) for vaso-occlusive crises (VOC) hospitalizations between 1997 and 2009.
  • To identify demographic and clinical factors associated with LOS for pediatric SCD VOC hospitalizations.

Main Methods:

  • Analysis of the Kid's Inpatient Database (1997, 2003, 2009), a national sample of pediatric discharges (ages 0-18).
  • Inclusion criteria: primary or secondary diagnosis of SCD with crisis.
  • Statistical analysis included bivariate and multivariate linear regression to assess factors influencing LOS.

Main Results:

  • A marginal decrease in the number and proportion of pediatric VOC hospitalizations was observed from 1997 to 2009.
  • Mean LOS for VOC hospitalizations significantly decreased from 4.59 to 4.21 days.
  • Older age was consistently associated with longer LOS; adolescents experienced the most significant LOS reduction.

Conclusions:

  • Hospital data reveal a modest yet significant reduction in LOS for pediatric VOC hospitalizations over a 12-year period.
  • Adolescents, despite showing the largest LOS decrease, still represent a substantial portion of VOC inpatient stays.
  • The adolescent period is identified as a critical phase for targeted interventions in managing SCD VOC.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...